Cholinergic basal forebrain degeneration due to sleep-disordered breathing exacerbates pathology in a mouse model of Alzheimer's disease.
Level 5 - mechanism / opinion, no new human data
Preclinical animal study.
PubMed 36323689 · doi:10.1038/s41467-022-33624-y
What was done
Researchers developed a mouse model of sleep-disordered breathing (SDB) reproducing key human features, including sleep disruption, altered breathing during sleep, moderate hypoxemia, and cognitive deficits. They applied this SDB paradigm to a familial Alzheimer's disease (AD) mouse model and compared outcomes to chronic hypoxia alone and sleep disruption alone. They also assessed the role of nuclear hypoxia-inducible factor 1 alpha (HIF-1α) and tested whether restoring blood oxygen levels during sleep prevented pathological changes.
What was found
Inducing SDB in familial AD mice exacerbated cognitive impairment, increased amyloid-beta and inflammatory markers, and selectively caused degeneration of cholinergic basal forebrain neurons. Neither chronic hypoxia alone nor sleep disruption alone replicated these pathological features. Cholinergic neurodegeneration was mediated by the accumulation of nuclear HIF-1α, and restoring blood oxygen levels during sleep prevented the SDB-induced pathology. The abstract provided qualitative findings without numerical metrics or effect sizes.
Why it matters
The study outlines a mechanistic signaling pathway connecting sleep-disordered breathing to accelerated Alzheimer's pathology through hypoxia-driven cholinergic basal forebrain degeneration, highlighting nocturnal oxygen restoration as a candidate intervention.
Limits
The study was conducted entirely in transgenic mouse models of familial Alzheimer's disease, which may not capture human sporadic disease complexity. Animal sample sizes, quantitative effect estimates, and statistical margins were not reported in the abstract.
Cited by
- context Research from the Queensland Brain Institute at the University of Queensland found that individuals with untreated sleep apnea have a 45% higher risk of developing Alzheimer's disease.